Well, if you look at any drug pipeline or medical discovery pipeline, I think you have to fund a hundred seed projects to get one to actually pay off. I think the balance has to be very strongly on the research side, because it's very hard to pick the winner. You basically need the marketplace to ultimately tell you who wins and who loses.
I would say it's 80% basic research and 20% transitional funding to get it into industry, and then industry has to take some risk.